Aignostics is a Berlin-based AI company that transforms multi-modal pathology data into insights for biopharmaceutical clients.

CorFlow Therapeutics AG develops and validates the CoFl system for diagnosing and treating Microvascular Obstruction (MVO) in heart attack patients.

MinervaX is a Danish biotechnology company that has raised EUR 54 million to advance the development of its maternal vaccine against Group B Streptococcus (GBS), a leading cause of life-threatening infections in newborns.